Increased Focus on Protein Intake Among Geriatric Patients
NCT ID: NCT03075189
Last Updated: 2018-05-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
18 participants
INTERVENTIONAL
2017-03-07
2017-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Assessments will be performed at baseline, on the day of discharge and 4 weeks after discharge (follow up).
The primary outcome is change in protein intake from Baseline to 4 weeks after discharge.
The hypothesis is that serving of individually selected protein enriched snack/dish in the morning and before bedtime during hospitalization results in higher protein intake during hospitalization and that this experience combined with dietary counseling at discharge, results in a higher protein intake at 28 days after discharge. Further, we hypothesize that the increased protein intake will affect functional level, hand grip strength, sarcopenic status and quality of life in geriatric patients and will lead to shorter LOS and fewer readmission frequency.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Strength Training and Protein Ingestion in Old Versus Very-old
NCT02105922
The Importance of Additional Protein to Benefit More From Training During and After Hospitalization
NCT02717819
Increase Protein Intake in Elderly
NCT01907152
Counteracting Age-related Loss of Skeletal Muscle Mass
NCT02034760
The (Cost)Effectiveness of Increasing Protein Intake on Physical Funtioning in Older Adults
NCT03712306
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Contrary to the masked officials two non-masked officials are responsible for randomization, serving of meals, diet registration and dietary counseling.
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Protein supplement
During hospitalization the intervention group will receive a protein enriched snack/meal in the morning and before bedtime. They will be given 15 gr of protein every morning, and the meal before bedtime will vary in protein content according to the individual needs. Diet registration will be carried out every day during hospitalization. At discharge, participants in the intervention will be instructed and advised with focus on consuming more protein at home.
Diet registration and testing at baseline, discharge and follow-up.
Whey protein supplement
During hospitalization the intervention group will receive a whey protein enriched snack/meal in the morning and before bedtime. They will be given 15 gr of protein every morning, and the meal before bedtime will vary in protein content according to the individual needs. Diet registration will be carried out every day during hospitalization. At discharge, participants in the intervention will be instructed and advised with focus on consuming more protein at home.
The control group are having the ordinary hospital diet and are following normal guidelines. They are not offered the protein focused counseling at discharge.
Both groups have diet registration and testing at baseline, discharge and follow-up.
Standard treatment
The control group are having the ordinary hospital diet and are following normal guidelines. They are not offered the protein focused counseling at discharge.
Diet registration and testing at baseline, discharge and follow-up.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Whey protein supplement
During hospitalization the intervention group will receive a whey protein enriched snack/meal in the morning and before bedtime. They will be given 15 gr of protein every morning, and the meal before bedtime will vary in protein content according to the individual needs. Diet registration will be carried out every day during hospitalization. At discharge, participants in the intervention will be instructed and advised with focus on consuming more protein at home.
The control group are having the ordinary hospital diet and are following normal guidelines. They are not offered the protein focused counseling at discharge.
Both groups have diet registration and testing at baseline, discharge and follow-up.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Expected length-of-stay, LOS: more than 3 days
* Normal kidney function. (As long as the kidney values remain stable during the intervention it is deemed safe to take part, as the amount of protein given will not exceed the amount recommended by the Danish authorities.
Exclusion Criteria
* Patients exclusively fed by tube/probe or parenteral nutrition.
* Gastrointestinal problems, that makes normal food intake impossible.
* People suffering from dementia, deliriousness or severe memory loss
* Patients abusing alcohol
* Patients in isolation
* Terminal patients
* Patients that do not speak Danish or English
* Patients suffering from food allergies/intolerances that makes it impossible to accommodate to the protein enriched foods.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Slagelse Hospital
OTHER
Arla Foods
INDUSTRY
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Lars Holm
Associate professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Slagelse Hospital
Slagelse, Ingemannsvej 18, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16045350
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.